|

Injective Price Prediction: INJ becomes attractive to buy after a 20% fall

  • Injective price dipped nearly 20%, succumbing to broader market crash on Friday.
  • INJ is likely not to be left behind, trapping shorters for breakdown contingent on Bitcoin price showing strength.
  • A break and close below $20.00 would invalidate the bullish thesis.

Injective (INJ) price succumbed to the Friday crash that was instigated by Bitcoin price dumping to whiplash hundreds of millions in long and short positions. For late bulls, however, this could be the ideal discounted entry as the BTC halving closes in.

Also Read: Injective price coils up for a breakout after deep 40% correction

Injective price coils up for a rally

Injective price dipped nearly 20% on Friday, clearing the January 3 low of $29.21. The move could be a swift liquidity grab, triggered by large sell orders that quickly absorb available liquidity in the market. Participants may rush to capitalize on perceived opportunities, resulting in rapid price movements and fluctuations in liquidity.

With the Relative Strength Index (RSI) below 30, INJ is already oversold and may be due for a pullback. The likely play incase of a correction would be a flip of the $29.27 blockade into support, followed by a retest of this resistance-support before an extended move to the 50% Fibonacci placeholder at $37.24.

A move beyond $37.24 would encourage more buy orders with the gains likely to see the Injective price extend a neck higher to tag the $45.21. In a highly bullish case, INJ price could clear the aforementioned level to reclaim the $53.00 peak. This would denote a climb of nearly 98% above current levels. The forecasted recovery is contingent on how soon Bitcoin price recovers, and the broader cryptocurrency market with it.

INJ/USDT 1-day chart

On the other hand, if the bears fasten their hands, the Injective price could extend the fall. A drop below the Friday bottom of $22.77 would produce a lower low, invalidating the bullish thesis. 

Author

Lockridge Okoth

Lockridge is a believer in the transformative power of crypto and the blockchain industry.

More from Lockridge Okoth
Share:

Editor's Picks

Hyperliquid Price Forecast: HYPE rises on commodities demand amid US-Iran war

Hyperliquid (HYPE) steadies above $33 at press time on Tuesday, marking its fourth consecutive day of recovery in a broadly volatile market due to the ongoing US-Israel strikes on Iran.

Stellar Price Forecast: XLM risks deeper losses as derivatives metrics turn negative

Stellar is trading red below $0.16 at the time of writing, after a slight recovery the previous day. Weakening derivatives data caps the recovery, while an unfavorable technical outlook projects a deeper correction for the XLM token in the upcoming days.

Aave Price Forecast: AAVE tests channel resistance as ParaFi Capital deposit, bearish derivatives data caps upside

Aave (AAVE) trades around $120 on Tuesday, testing the channel resistance, signaling that sellers remain active in the zone. Lookonchain data shows that ParaFi Capital transferred 42,000 AAVE tokens to Coinbase Prime over the past 10 hours, often interpreted as a potential selling signal.

CME Group's futures suite now covers over 75% of total crypto market cap

CME Group announced that its crypto futures offering now covers over 75% of the total digital asset market cap, following the launch of its Cardano (ADA), Chainlink (LINK) and Stellar (XLM) products.

Bitcoin Price Annual Forecast: BTC holds long-term bullish structure heading into 2026

Bitcoin (BTC) is wrapping up 2025 as one of its most eventful years, defined by unprecedented institutional participation, major regulatory developments, and extreme price volatility.

Bitcoin: Another month of losses, and it’s been five

Bitcoin (BTC) price is stabilizing around $68,000 at the time of writing on Friday, but the Crypto King is poised to close February on a fragile footing, marking its fifth consecutive month of losses since October and a rare start to the year with back-to-back monthly corrections.